97 related articles for article (PubMed ID: 8150036)
1. Evidence suggesting a negative regulatory role for macrophages in murine erythropoiesis in vivo.
Wang CQ; Udupa KB; Xiao H; Lipschitz DA
Exp Hematol; 1994 Apr; 22(4):370-6. PubMed ID: 8150036
[TBL] [Abstract][Full Text] [Related]
2. The role of macrophages in the regulation of erythroid colony growth in vitro.
Wang CQ; Udupa KB; Lipschitz DA
Blood; 1992 Oct; 80(7):1702-9. PubMed ID: 1391939
[TBL] [Abstract][Full Text] [Related]
3. Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro.
Wang CQ; Udupa KB; Lipschitz DA
J Cell Physiol; 1996 Feb; 166(2):305-10. PubMed ID: 8591990
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.
Wang CQ; Udupa KB; Lipschitz DA
J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445
[TBL] [Abstract][Full Text] [Related]
5. Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.
Johnson CS; Pourbohloul SC; Furmanski P
Exp Hematol; 1991 Feb; 19(2):101-5. PubMed ID: 1991491
[TBL] [Abstract][Full Text] [Related]
6. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
7. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
8. Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages.
Smith MA; Knight SM; Maddison PJ; Smith JG
Ann Rheum Dis; 1992 Jun; 51(6):753-7. PubMed ID: 1616358
[TBL] [Abstract][Full Text] [Related]
9. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
10. Negative regulators may mediate some of the inhibitory effects of HIV-1 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term cultures.
Schwartz GN; Kessler SW; Szabo JM; Burrell LM; Francis ML
J Leukoc Biol; 1995 Jun; 57(6):948-55. PubMed ID: 7540643
[TBL] [Abstract][Full Text] [Related]
11. Effect of age on marrow macrophage number and function.
Wang CQ; Udupa KB; Xiao H; Lipschitz DA
Aging (Milano); 1995 Oct; 7(5):379-84. PubMed ID: 8719605
[TBL] [Abstract][Full Text] [Related]
12. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
13. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates.
Liang DC; Shih LY; Kuo MC; Chai IJ; Su TH; Chen SH; Liu HC; Shimosaka A
Pediatr Hematol Oncol; 2001 Sep; 18(6):383-91. PubMed ID: 11554233
[TBL] [Abstract][Full Text] [Related]
17. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
18. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
Reid CD; Stackpoole A; Meager A; Tikerpae J
J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
[TBL] [Abstract][Full Text] [Related]
19. Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumor necrosis factor.
Furmanski P; Johnson CS
Blood; 1990 Jun; 75(12):2328-34. PubMed ID: 2350578
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hemopoietic activities in media conditioned by a murine marrow-derived adherent cell line, B.Ad.
Li CL; Culter RL; Johnson GR
Exp Hematol; 1987 May; 15(4):373-81. PubMed ID: 3494626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
